The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
JAAD Case Reports
(Sep 2022)
Annular lichenoid eruption following treatment with casirivimab/imdevimab for COVID-19
Netana H. Markovitz, MD,
Elisabeth Pedersen, MD, PhD,
Dana L. Sachs, MD,
Scott C. Bresler, MD, PhD
Affiliations
Netana H. Markovitz, MD
University of Michigan Medical School, Ann Arbor, Michigan; Correspondence to: Netana H. Markovitz, MD, 1301 Catherine st, Ann Arbor, MI, 48109.
Elisabeth Pedersen, MD, PhD
Michigan Medicine Department of Dermatology, Ann Arbor, Michigan
Dana L. Sachs, MD
Michigan Medicine Department of Dermatology, Ann Arbor, Michigan
Scott C. Bresler, MD, PhD
Michigan Medicine Department of Dermatology, Ann Arbor, Michigan; Michigan Medicine Department of Pathology, Ann Arbor, Michigan
Journal volume & issue
Vol. 27
pp. 156 – 158
Abstract
Read online
No abstracts available.
Keywords
casirivimab
COVID-19 antiviral
drug eruption
drug reaction
imdevimab
lichenoid reaction
WeChat QR code
Close